Deep molecular responses for treatment‐free remission in chronic myeloid leukemia

por Dulucq, Stéphanie, Mahon, Francois‐Xavier
Publicado 2016

What is treatment free remission in chronic myeloid leukemia?

por Rea, Delphine, Etienne, Gabriel, Mahon, François-Xavier
Publicado 2017

A Single Nucleotide Polymorphism in cBIM Is Associated with a Slower Achievement of Major Molecular Response in Chronic Myeloid Leukaemia Treated with Imatinib

por Augis, Vanessa, Airiau, Kelly, Josselin, Marina, Turcq, Béatrice, Mahon, François-Xavier, Belloc, Francis
Publicado 2013

PB1972: ASC4START: A PHASE IIIB, OPEN-LABEL, RANDOMIZED STUDY OF ASCIMINIB VERSUS NILOTINIB IN PATIENTS WITH NEWLY DIAGNOSED PH+ CHRONIC MYELOGENOUS LEUKEMIA IN CHRONIC PHASE

por Hochhaus, Andreas, Saussele, Susanne, Mahon, Francois-Xavier, Pilipovic, Virginia, Zhang, Yifan, Schuld, Peter, Brümmendorf, Tim H
Publicado 2023

A genome‐scale CRISPR knock‐out screen in chronic myeloid leukemia identifies novel drug resistance mechanisms along with intrinsic apoptosis and MAPK signaling

por Lewis, Matthieu, Prouzet‐Mauléon, Valérie, Lichou, Florence, Richard, Elodie, Iggo, Richard, Turcq, Béatrice, Mahon, François‐Xavier
Publicado 2020

A tyrosine kinase-STAT5-miR21-PDCD4 regulatory axis in chronic and acute myeloid leukemia cells

por Espadinha, Anne-Sophie, Prouzet-Mauléon, Valérie, Claverol, Stéphane, Lagarde, Valérie, Bonneu, Marc, Mahon, François-Xavier, Cardinaud, Bruno
Publicado 2017

Dasatinib-Loaded Erythrocytes Trigger Apoptosis in Untreated Chronic Myelogenous Leukemic Cells: A Cellular Reservoir Participating in Dasatinib Efficiency

por Airiau, Kelly, Turcq, Béatrice, Bouchet, Stéphane, Laharanne, Elodie, Vial, Jean-Philippe, Etienne, Gabriel, Mahon, François-Xavier, Belloc, Francis
Publicado 2018

Mycophenolic Acid Overcomes Imatinib and Nilotinib Resistance of Chronic Myeloid Leukemia Cells by Apoptosis or a Senescent-Like Cell Cycle Arrest

por Drullion, Claire, Lagarde, Valérie, Gioia, Romain, Legembre, Patrick, Priault, Muriel, Cardinaud, Bruno, Lippert, Eric, Mahon, François-Xavier, Pasquet, Jean-Max
Publicado 2012

Novel analytical methods to interpret large sequencing data from small sample sizes

por Lichou, Florence, Orazio, Sébastien, Dulucq, Stéphanie, Etienne, Gabriel, Longy, Michel, Hubert, Christophe, Groppi, Alexis, Monnereau, Alain, Mahon, François-Xavier, Turcq, Béatrice
Publicado 2019

α-Defensin 1-3 And α-Defensin 4 as Predictive Markers of Imatinib Resistance and Relapse in CML Patients

por Etienne, Gabriel, Dupouy, Maryse, Costaglioli, Patricia, Chollet, Claudine, Lagarde, Valérie, Pasquet, Jean-Max, Reiffers, Josy, Garbay, Bertrand, Mahon, François-Xavier, Turcq, Béatrice
Publicado 2011

Synergistic cooperation between ABT-263 and MEK1/2 inhibitor: effect on apoptosis and proliferation of acute myeloid leukemia cells

por Airiau, Kelly, Prouzet-Mauléon, Valérie, Rousseau, Benoit, Pigneux, Arnaud, Jeanneteau, Marie, Giraudon, Manon, Allou, Kaoutar, Dubus, Pierre, Belloc, Francis, Mahon, François-Xavier
Publicado 2015

Evaluation of cardiovascular ischemic event rates in dasatinib-treated patients using standardized incidence ratios

por Saglio, Giuseppe, le Coutre, Philipp, Cortes, Jorge, Mayer, Jiří, Rowlings, Philip, Mahon, François-Xavier, Kroog, Glenn, Gooden, Kyna, Subar, Milayna, Shah, Neil P.
Publicado 2017

The Necrotic Signal Induced by Mycophenolic Acid Overcomes Apoptosis-Resistance in Tumor Cells

por Guidicelli, Gwendaline, Chaigne-Delalande, Benjamin, Dilhuydy, Marie-Sarah, Pinson, Benoît, Mahfouf, Walid, Pasquet, Jean-Max, Mahon, François-Xavier, Pourquier, Philippe, Moreau, Jean-François, Legembre, Patrick
Publicado 2009

Preclinical evaluation of Imatinib does not support its use as an antiviral drug against SARS-CoV-2

por Touret, Franck, Driouich, Jean-Sélim, Cochin, Maxime, Petit, Paul Rémi, Gilles, Magali, Barthélémy, Karine, Moureau, Grégory, Mahon, Francois-Xavier, Malvy, Denis, Solas, Caroline, de Lamballerie, Xavier, Nougairède, Antoine
Publicado 2021

Variable Behavior of iPSCs Derived from CML Patients for Response to TKI and Hematopoietic Differentiation

por Bedel, Aurélie, Pasquet, Jean- Max, Lippert, Éric, Taillepierre, Miguel, Lagarde, Valérie, Dabernat, Sandrine, Dubus, Pierre, Charaf, Lucie, Beliveau, François, de Verneuil, Hubert, Richard, Emmanuel, Mahon, François-Xavier, Moreau-Gaudry, François
Publicado 2013

Killer immunoglobulin‐like receptor genotypes and chronic myeloid leukemia outcomes after imatinib cessation for treatment‐free remission

por Dumas, Pierre‐Yves, Bérard, Emilie, Bréal, Claire, Dulucq, Stéphanie, Réa, Delphine, Nicolini, Franck, Forcade, Edouard, Dufossée, Melody, Pasquet, Jean‐Max, Turcq, Béatrice, Bidet, Audrey, Milpied, Noel, Déchanet‐Merville, Julie, Lafarge, Xavier, Etienne, Gabriel, Mahon, François‐Xavier
Publicado 2019

Chronic myeloid leukemia progenitor cells require autophagy when leaving hypoxia-induced quiescence

por Ianniciello, Angela, Dumas, Pierre-Yves, Drullion, Claire, Guitart, Amélie, Villacreces, Arnaud, Peytour, Yan, Chevaleyre, Jean, Brunet de la Grange, Philippe, Vigon, Isabelle, Desplat, Vanessa, Priault, Muriel, Sbarba, Persio Dello, Ivanovic, Zoran, Mahon, François-Xavier, Pasquet, Jean-Max
Publicado 2017

MiR-10a and HOXB4 are overexpressed in atypical myeloproliferative neoplasms

por Dumas, Pierre-Yves, Mansier, Olivier, Prouzet-Mauleon, Valerie, Koya, Junji, Villacreces, Arnaud, Brunet de la Grange, Philippe, Luque Paz, Damien, Bidet, Audrey, Pasquet, Jean-Max, Praloran, Vincent, Salin, Franck, Kurokawa, Mineo, Mahon, François-Xavier, Cardinaud, Bruno, Lippert, Eric
Publicado 2018

Incidence and outcome of BCR‐ABL mutated chronic myeloid leukemia patients who failed to tyrosine kinase inhibitors

por Etienne, Gabriel, Dulucq, Stéphanie, Huguet, Françoise, Schmitt, Anna, Lascaux, Axelle, Hayette, Sandrine, Fort, Marie‐Pierre, Sujobert, Pierre, Bijou, Fontanet, Morisset, Stéphane, Tavitian, Suzanne, Bidet, Audrey, Turcq, Beatrice, Robbesyn, Fanny, Chollet, Claudine, Belloc, Francis, Durrieu, Françoise, Mahon, François‐Xavier, Nicolini, Franck E.
Publicado 2019

Antimetabolic cooperativity with the clinically approved l-asparaginase and tyrosine kinase inhibitors to eradicate CML stem cells

por Trinh, Anne, Khamari, Raeeka, Fovez, Quentin, Mahon, François-Xavier, Turcq, Béatrice, Bouscary, Didier, Maboudou, Patrice, Joncquel, Marie, Coiteux, Valérie, Germain, Nicolas, Laine, William, Dekiouk, Salim, Jean-Pierre, Sandrine, Maguer-Satta, Veronique, Ghesquiere, Bart, Idziorek, Thierry, Quesnel, Bruno, Kluza, Jerome, Marchetti, Philippe
Publicado 2021